• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vanda Pharmaceuticals (NQ: VNDA )

    4.890 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Vanda Pharmaceuticals

    < Previous 1 2 3 4 Next >
    Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
    HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology. 
    Via Benzinga
    Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
    A regulator's decision drained the market's enthusiasm for the company. 
    Via The Motley Fool
    FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
    The FDA rejected Vanda Pharmaceuticals' new drug application for tradipitant to treat gastroparesis, citing the need for more studies despite delays in its review process. Vanda argues the drug meets... 
    Via Benzinga
    Exposures Product Safety
    What's Going On With Vanda Pharmaceuticals Shares Today?
    Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of response. 
    Via Benzinga
    Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
    Future Pak wants Vanda, but Vanda doesn't want Future Pak. 
    Via The Motley Fool
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal
    Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurological conditions. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning! 
    Via InvestorPlace
    Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    VNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024
    VNDA stock results show that Vanda Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
    "Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact." 
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21.... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
    Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. Board asserts resilient business with FDA-approved products. Future Pak... 
    Via Benzinga
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. 
    Via Benzinga
    Why Is Trio Petroleum (TPET) Stock Down 22% Today?
    Trio Petroleum stock is falling on Wednesday as TPET investors learn of a securities purchase agreement and Senior Secured Note. 
    Via InvestorPlace
    Why Is Trilogy Metals (TMQ) Stock Down 29% Today?
    Trilogy Metals stock is falling on Wednesday as TMQ investors react to reports that the government plans to block its Ambler Access Project. 
    Via InvestorPlace
    Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today?
    Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday! 
    Via InvestorPlace
    Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings
    U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% to 16,315.68. The S&P 500 also... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... 
    Via Benzinga
    Exposures Glyphosate
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; ISM Services PMI Falls In March
    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up 0.18% to 39,241.00 while the NASDAQ rose 0.55% to 16,329.45. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.